In the May issue of PME we look at patient engagement and hear how some of the structural barriers within the industry are working against some of its initiatives.
One project that hasn’t been held up is Astellas’ Action on Fistula and there’s a case study of this ‘good pharma’ initiative that shows how it’s transforming patients’ lives in Kenya.
Looking at pharma’s customers, we examine how to deliver a great experience and how companies could increase both satisfaction and trust.
For this month’s lead interview article we turn to the biotech sector and Tiziana Life Sciences’ Kunwar Shailubhai, who tells us about his firm’s work to establish itself and tackle unmet needs.
Elsewhere in this issue of PME you’ll find advice on meeting orphan drugs’ market access challenges in Europe, where some 30 million people are thought to be living with a rare disease.
Register here to receive email notification of future digital editions of PME or contact the subscriptions department to enquire about receiving a print copy of the magazine. More PMLiVE digital editions can be found here.
PME is also available to download as an app for iPhone and iPad
